Search results

  1. J

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    I can paste into translate 1st page REPORTING FUNCTION LEVEL Study ID number:…….. This form should be completed every two weeks from the start of the study until week 28 of the study, and every four weeks for the remaining time, from weeks 32 to 52. For each time point, we ask that you state...
  2. J

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    I got the functionality questionnaire from Bergen. Anyone can help with a quick translation? @Utsikt Thanks.
  3. J

    Polybio Fall Symposium 2025

    Not a recommendation. https://polybio.org/fall-2025-symposium/
  4. J

    Preprint Virus Genome Sequences in the Blood of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients, 2025, Davis et al

    Here is Polybio, who are very enthusiastic about viral persistence https://polybio.org/cutting-edge-recommendations-provide-treatment-path-for-millions-of-long-covid-patients/ “However, Long COVID is not a mystery. Research increasingly links the condition and its symptoms to persistent...
  5. J

    Dr Ron Davis - Updates on ME/CFS research - September 2019 onwards

    RD—Lot of oxidative damage in patients—found by one of Mark Davis’ graduate students.
  6. J

    Dr Ron Davis - Updates on ME/CFS research - September 2019 onwards

    New video RD and Systrom Some people with a mutation benefit from a specific yogurt. Which yogurt?
  7. J

    CrunchME

    Merged posts --------------------- Was this posted anywhere? Is it from a paper? Thanks.
  8. J

    Evaluation of Interventions for Cognitive Symptoms in Long COVID, 2025, Knopman et al

    Holy crap. Couldn’t fit all those people on the Titanic.
  9. J

    Evaluation of Interventions for Cognitive Symptoms in Long COVID, 2025, Knopman et al

    Hopefully this will put a nail in the coffin in this line of research, but somehow I doubt it.
  10. J

    Evaluation of Interventions for Cognitive Symptoms in Long COVID, 2025, Knopman et al

    https://recovercovid.org/news/recover-neuro-clinical-trial-shares-results-three-non-drug-treatments-cognitive-symptoms-long In other words, didn’t work.
  11. J

    What will it take for AI to change drug discovery? R. Teslo

    https://open.substack.com/pub/ruxandrabio/p/what-will-it-take-for-ai-to-change?r=7y4i4&utm_medium=ios We do not need more hypotheses, we need better ones
  12. J

    How do we stop charities and influencers spreading bio-babble about ME/CFS?'

    Don’t forget about the virus people! “From Crisis to Cure: PolyBio is supporting top HIV researchers to pivot into the study and treatment of Long COVID. Watch the full video to learn how this collaboration is being maximized & driving forward innovative research: youtu.be/6kC1lyY6hPc?si…”...
  13. J

    Review Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease, 2025, de Canson et al

    Exactly. How could you include patients with LC lung damage together with ME/CFS patients and expect to get any coherent results?
  14. J

    Review Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease, 2025, de Canson et al

    Some interesting affiliations Department of Theoretical Philosophy, University of Groningen, Groningen 9712 GL, Netherlands e New York, NY, USA Are there non-theoretical philosophy departments?
  15. J

    Daratumumab, isatuximab (CD38 drugs)

    Agree with above….he hasn’t measured NK cells prior to treatment.
Back
Top Bottom